Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Duowei Pharmaceutical Group is a large-scale Chinese pharmaceutical enterprise specializing in the research, development, and manufacturing of active pharmaceutical ingredients (APIs), finished dosages, and animal health products. The company is globally recognized as one of the world's largest producers of Vitamin B12 and a major manufacturer of macrolide antibiotics such as Tylosin and Tilmicosin. With significant production bases in Ningxia and Inner Mongolia, Duowei operates across the entire value chain, from large-scale fermentation and chemical synthesis to final product distribution. Their portfolio serves diverse sectors including human nutrition, clinical medicine, and the global veterinary industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 多维医药集团.